Skip to main content
SAMIL PHARMACEUTICAL CO.,LTD logo

SAMIL PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 000520 ISIN · KR7000520007 KO Manufacturing
Open in API
Filings indexed 336 across all filing types
Latest filing 2021-09-15 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 000520

About SAMIL PHARMACEUTICAL CO.,LTD

https://www.samil-pharm.com/main/EN

Samil Pharmaceutical Co., Ltd. is a company engaged in the research, development, and manufacturing of pharmaceutical products. The company specializes in ophthalmology and also produces a diverse portfolio of drugs for other therapeutic areas, including the central nervous system (CNS), hepatic conditions, and gastrointestinal disorders. Its product range encompasses prescription medicines as well as over-the-counter remedies for common ailments like fever and colds. In addition to developing its own products, Samil Pharmaceutical offers Contract Development and Manufacturing Organization (CDMO) services to global partners. The company emphasizes research and development and collaborates with other leading pharmaceutical firms.

Recent filings

Filing Released Lang Actions
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Samil Pharmaceutical regarding the adjustment of the exercise price for warrants (신주인수권행사가액의 조정) due to a decline in market price. This type of disclosure relates to changes in capital structure and financial instruments, which falls under the 'Capital/Financing Update' category. It is not a report publication announcement, but a direct disclosure of a corporate action affecting equity-linked debt.
2021-09-15 Korean
반기보고서 (2021.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for Samil Pharmaceutical Co., Ltd. for the period ending June 30, 2021. It contains comprehensive financial data, management discussion, and operational details, which fits the definition of an Interim/Quarterly Report (IR). H1 2021
2021-08-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share acquisition (장내매수) by an executive (허준범) of the company (삼일제약). This type of filing is a standard disclosure for insider trading/director dealings in the Korean market, which corresponds to the 'Director's Dealing' category.
2021-08-06 Korean
신탁계약에의한취득상황보고서
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on Acquisition Status by Trust Contract' (신탁계약등에의한취득상황보고서) filed with the Financial Supervisory Service (FSS) in South Korea. It details the company's (Samil Pharmaceutical) purchase of its own shares through a trust agreement with NH Investment & Securities. This type of filing, which reports the company's activity in buying back its own shares, falls under the 'Transaction in Own Shares' category.
2021-07-30 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) filed by Samil Pharmaceutical. It details specific changes in share ownership by major shareholders and related parties, including names, relationship to the company, and the number of shares changed. This falls under the category of 'Major Shareholding Notification' (MRQ), as it tracks changes in significant ownership levels.
2021-07-30 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on the Status of Large Shareholdings' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (DART system) used when an entity acquires 5% or more of a company's shares. It details the reporting entity (NH Investment & Securities), the target company (Samyil Pharmaceutical), the purpose of holding (simple investment), and specific transaction details. This falls under the 'Major Shareholding Notification' category.
2021-06-18 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.